Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma

Click to increase image sizeClick to decrease image size Authors’ contributionsMK: analyzed the cases and wrote the manuscript. MJK: critically reviewed the article and supervised the findings of this work. BC and PZ: wrote and analyzed case 2. RDB, MB and CT: wrote and analyzed case 3. AS, BB, WK: critically reviewed the article and analyzed case 1.Disclosure statementNo potential conflict of interest was reported by the authors.Additional informationFundingThe author(s) reported there is no funding associated with the work featured in this article.